Aditxt stock.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Aditxt stock. Things To Know About Aditxt stock.

17 thg 8, 2023 ... Aditxt®, Inc. (NASDAQ: ADTX) is a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system ...Aug 17, 2023 · Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ... Get the latest Aditxt Inc (ADTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.14 hours ago ... ADTX has a roughly average overall score of 40 meaning the stock holds a better value than 40% of stocks at its current price.Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock (or pre-funded warrant in lieu thereof) at a purchase price of $10.00 ...

Track Aditxt Inc (ADTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune …

Aditxt, Inc. (ADTX) is a global innovation activation company that discovers, develops, and deploys technologies that monitor and modulate the immune system. The stock price, news, quote, history, and research reports of ADTX are available on Yahoo Finance. See the latest updates on its performance outlook, earnings date, dividend yield, and more.

ADTX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Aditxt, Inc. in the last 3 months. The average price target is $61.00 with a high forecast of $61.00 and a low forecast of $61.00. The average price target represents a 1237.72% change from the last price of $4.56.All values updated annually at fiscal year end. Earnings Per Share -595.50. Sales 20.14. Tangible Book Value 47.38. Operating Profit -537.79. Working Capital 10.22. Long Term Liabilities 17.51 ...What percentage of Aditxt stock is owned by insiders? 1.23% of Aditxt stock is owned by insiders. Learn more on ADTX's insider holdings. Which Aditxt insiders have been buying company stock? The following insider purchased ADTX shares in the last 24 months: Amro A Albanna ($0.00).Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ...

Find the latest Aditxt, Inc. (ADTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Adam Smigielski. Aditxt ( NASDAQ: ADTX) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the ...

Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. What To ...On April 3, 2023, Aditxt subsidiary, Pearsanta, Inc. (“Pearsanta”) submitted a bid to acquire substantially all of Lucira Health Inc.’s (“Lucira”) assets, which included Lucira Connect and FDA-approved at-home combination COVID-19 and flu tests. At the bankruptcy auction, which was held on April 6, 2023, Pearsanta was chosen as the ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Stock Quote ChartingAccording to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.

17 Nov 2023 ... Amro Albanna, CEO of Aditxt, Inc., was recently interviewed by Benzinga. Aditxt is an innovation platform commercializing promising ...Aditxt Inc stock quote and company news. Get the latest ADTX company stock news & quotes.Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. RICHMOND, Va., September 06, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it ...Supported by clinical researchers, chemists, computer science and biostatisticians teams, the Aditxt platforms will unlock next-level technologies and therapies. These innovations will fuel the frontline work in the fight against diseases. Apr 20, 2023 · Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ...

Sep 13, 2022 · Aditxt (NASDAQ:ADTX) stock climbed ~32% postmarket on Tuesday after the firm effected a 1-for-50 reverse stock split.The firm's stock will trade on a post-split basis under the ticker "ADTX" after ... Certain Common Stock of Aditxt, Inc. are subject to a Lock-Up Agreement Ending on 24-JUL-2023. Jul. 23: CI Aditxt, Inc. announced that it has received $0.001 million in funding Jul. 10: CI Aditxt, Inc. announced that it has received $0.25 million in funding Jul. 02: CI

Aditxt, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Aditxt, Inc. Stock | ADTX | US0070256047Webull offers ADTX stock news, real time Aditxt Inc news help you invest smart.Aditxt has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%. Is Aditxt Stock Undervalued? The current Aditxt [ ADTX] share price is $9.05. The Score for ADTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace Musk’s “Project Omega” May Be Set to Mint ... Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended. ...31 thg 8, 2023 ... Aditxt Inc (ADTX) has risen Thursday morning, with the stock climbing 5.31% in pre-market trading to 10.32. ADTX's short-term technical ...Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... 28 thg 8, 2020 ... timely and fast moving immune monitoring technology coming to commercial market. #investors #stock #biotech #smallcap

Supported by clinical researchers, chemists, computer science and biostatisticians teams, the Aditxt platforms will unlock next-level technologies and therapies. These innovations will fuel the frontline work in the fight against diseases.

Aditxt Inc is lower by Tuesday morning, with the stock declining -18.96% in pre-market trading to 33.52.ADTX's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market.

Nov 30, 2023 · Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. In conclusion, Aditxt Inc (ADTX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.Nov 30, 2023 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company.. There are no new ... Find out all the key statistics for Aditxt, Inc. (ADTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...All values updated annually at fiscal year end. Earnings Per Share -595.50. Sales 20.14. Tangible Book Value 47.38. Operating Profit -537.79. Working Capital 10.22. Long Term Liabilities 17.51 ... Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. About Aditxt, Inc. Aditxt is a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system.Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...Aditxt stock price has plummeted: avoid at all cost. Aditxt (NASDAQ: ADTX) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year.

4 ngày trước ... ADTX #ADTXSTOCK #adtxstockprediction #Aditxt ADTX Stock - Aditxt Inc Stock Breaking News Today | ADTX Stock Price Prediction | ADTX Stock ...Aditxt, Inc. analysts consensus, targets, ratings and recommendations | Nasdaq: ADTX | NasdaqAditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...Instagram:https://instagram. mine shiba inuphev suvsfang stocks todayrick moore plumbing lakeland florida As previously reported by Aditxt, Inc. (the "Company") on a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the "SEC") on July 20, 2022, the Company received a letter from the Staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") stating that the … biggest etfsexxonmobil competitors Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock (or pre-funded …Company profile page for Aditxt Inc including stock price, company news, press releases, executives, board members, and contact information enel italy Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Item 1.01. Entry into a Material Definitive Agreement. On December 20, 2022, Aditxt, Inc. (the "Company"), entered into an At The Market Offering Agreement (the "ATM Agreement") with H.C. Wainwright & Co., LLC as agent (the "Agent"), pursuant to which the Company may offer and sell, from time to time through the Agent, shares of …RICHMOND, Va., August 31, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...